Background Medication for opioid use disorder (MOUD) is associated with substantial
reductions in the risk of mortality, and American and Canadian guidelines recommend it as …

Background Hospitalization of patients with opioid use disorder (OUD) is increasing, yet little
is known about opioid agonist therapy (OAT: methadone and buprenorphine) administration …

Background Medicaid recipients have a high burden of opioid overdose and opioid use
disorder (OUD). Opioid agonist therapies are an effective treatment for OUD, but there is a …

Background Substance use is common among people living with HIV and has been
associated with suboptimal HIV treatment outcomes. Integrating substance use services into …

Background People who use drugs experience pain at two to three times the rate of the
general population and yet continue to face substantial barriers to accessing appropriate …

Background: Adolescents with substance use disorders (SUD) should receive timely access
to treatment to improve lifelong outcomes. The Healthcare Effectiveness Data and …

Introduction Chronic pain and serious mental illness increase risk of opioid use, and opioid
use can exacerbate both conditions. Substance use disorder (SUD) treatment can be …

Shari L. Hutchison, MS, PMP, is the Project Director, Community Care Behavioral Health
Organization, has over 25 years of experience in program evaluation, working …

Background Improved knowledge of factors that influence treatment engagement could help
treatment providers and systems better engage patients. The present study used machine …

Aim Youth ages 12–24 account for approximately 20% of overdoses and yet are poorly
reached by opioid agonist treatment (OAT), the most widely recommended treatment for …